J&J's growth, new drug launches and pipeline strength support the stock, despite patent, MedTech and

Pulling $54,000 a year from a $950,000 rollover IRA sounds like a math problem, but the real trap is

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Morgan Stanl

https://youtu.be/H_RititNE8U

Year to date, the healthcare sector finds itself in the middle of the S&P 500's pack.

Few companies have a longer track record of uninterrupted dividend growth. This streak is likely to

Retiring on dividends at 60 sounds straightforward until you realize the yield tier you choose today

A $425,000 nest egg can generate wildly different monthly paychecks depending on where you put it, b

Replicating a Social Security check with dividends sounds straightforward until you realize the yiel

Defensive blue chips rarely dominate headlines, but heading into 2027, three of the market's most re

Aurora Investment Managers LLC. bought a new position in shares of Johnson and Johnson (NYSE: JNJ) i

The yield you chase at 52 could quietly cannibalize the very nest egg you need at 62. Before you rea

Chasing a $50,000 monthly dividend stream sounds like a math problem, but the yield you pick determi

A $1.25 million nest egg can fund a very different retirement depending on one number: your withdraw

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is

Jim Cramer praises Lockheed Martin and Ameriprise Financial, advises against Cipher Digital. Eli Lil

Armstrong Henry H Associates Inc. grew its stake in Johnson and Johnson (NYSE: JNJ) by 0.9% during t

The number that separates a comfortable retirement from a perpetual side hustle depends entirely on

Johnson and Johnson just committed over a billion dollars to flood the market with American-made con

These healthcare giants can deliver steady gains.

Volatility has been the theme of 2026. The VIX touched 31.05 in late March before settling back to a

Investors may want to brace for turbulence. But these stocks should hold up well.

Kathy Hochul says Trump's Medicare subsidy decision will raise prescription drug costs for 1.3 m

Avior Wealth Management LLC cut its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 15.9% d

An 8% yield looks like a shortcut to $80,000 a year without selling a single share, but the brokerag

Retirement portfolios in August 2026 face a specific puzzle. Bond yields have come off their highs,

Annuity payouts are the most competitive they have been in years, which makes the timing of this com

Replacing a six-figure salary with dividends is a math problem first, and the capital requirement sw

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 2026 Wells F

GS, JPM, TRV and JNJ stand out as Dow hits a new high amid an AI-driven tech sell-off, with these bl

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that Jennifer Ta

Boomers heading into Fall 2026 are doing what disciplined income investors always do in August: rota

Johnson & Johnson reached a $5.5 billion agreement to resolve remaining federal and state talc l

U.S. stock futures were mixed on Tuesday, as the Dow Jones and S&P 500 indices gained but Nasdaq

Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.

Raymond James analyst Jayson Bedford maintains Johnson & Johnson (NYSE:JNJ) with a Outperform

UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp d

The reasons why RBC Capital Markets maintains its stock rating.

RBC Capital analyst Shagun Singh reiterates Johnson & Johnson (NYSE:JNJ) with a Outperform an

A report on July 15, 2026 shows that Representative Thomas Kean from New Jersey sale stock in Alphab

Wells Fargo analyst Larry Biegelsen maintains Johnson & Johnson (NYSE:JNJ) with a Overweight

Morgan Stanley analyst Terence Flynn maintains Johnson & Johnson (NYSE:JNJ) with a Overweight

The transaction strengthens DePuy Synthes’ Spine portfolio and expands its position in the rapidly g

Johnson & Johnson (NYSE:JNJ) held its second-quarter earnings conference call on Wednesday. Belo

Johnson & Johnson beats Q2 2026 Wall Street estimates and raises full-year guidance as sales top

Companies Reporting Before The Bell • VCI Global (NASDAQ:VCIG) is estimated to report earnings for i

 Net trade sales were USD 2,435 million in the U.S. and USD 1,772 million in the rest of the world.

Johnson & Johnson (NYSE:JNJ) raises FY2026 Adj EPS guidance from $11.45-$11.65 to $11.60-$11.75

July 15, 2026: Polymarket traders expect the S&P 500 to open higher on Wednesday after cooler in

CNN Money Fear and Greed index improved, but remained in Fear zone. U.S. stocks mostly higher on inf